Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) shares traded down 1.3% during mid-day trading on Tuesday . The company traded as low as €19.22 ($19.81) and last traded at €19.50 ($20.10). 4,583,339 shares traded hands during mid-day trading, The stock had previously closed at €19.76 ($20.37).
Bayer Aktiengesellschaft Price Performance
The company has a debt-to-equity ratio of 129.94, a current ratio of 1.27 and a quick ratio of 0.72. The company has a market capitalization of $18.99 billion, a P/E ratio of -14.98, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The firm's 50-day moving average is €22.76 and its 200-day moving average is €25.79.
About Bayer Aktiengesellschaft
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Further Reading
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
